Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Embecta's share price for the quarter that ended in Dec. 2024 was $20.65. Embecta's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 58 Mil. Therefore, Embecta's market cap for the quarter that ended in Dec. 2024 was $1,200 Mil.
Embecta's quarterly market cap
increased
from Jun. 2024 ($721 Mil) to Sep. 2024 ($814 Mil) and
increased
from Sep. 2024 ($814 Mil) to Dec. 2024 ($1,200 Mil).
Embecta's annual market cap
declined
from Sep. 2022 ($1,643 Mil) to Sep. 2023 ($863 Mil) and
declined
from Sep. 2023 ($863 Mil) to Sep. 2024 ($814 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Embecta's Enterprise Value for Today is $2,122 Mil.
Embecta Market Cap Historical Data
The historical data trend for Embecta's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Embecta's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embecta's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Market Cap distribution charts can be found below:
* The bar in red indicates where Embecta's Market Cap falls into.
Embecta Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Embecta's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embecta (NAS:EMBC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Embecta Market Cap Related Terms
Thank you for viewing the detailed overview of Embecta's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EMBC has been successfully added to your 